278 related articles for article (PubMed ID: 21356330)
1. Clinical and histopathologic features of fluoroquinolone-induced liver injury.
Orman ES; Conjeevaram HS; Vuppalanchi R; Freston JW; Rochon J; Kleiner DE; Hayashi PH;
Clin Gastroenterol Hepatol; 2011 Jun; 9(6):517-523.e3. PubMed ID: 21356330
[TBL] [Abstract][Full Text] [Related]
2. Clinical and histologic features of azithromycin-induced liver injury.
Martinez MA; Vuppalanchi R; Fontana RJ; Stolz A; Kleiner DE; Hayashi PH; Gu J; Hoofnagle JH; Chalasani N
Clin Gastroenterol Hepatol; 2015 Feb; 13(2):369-376.e3. PubMed ID: 25111234
[TBL] [Abstract][Full Text] [Related]
3. Amoxicillin-Clavulanate-Induced Liver Injury.
deLemos AS; Ghabril M; Rockey DC; Gu J; Barnhart HX; Fontana RJ; Kleiner DE; Bonkovsky HL;
Dig Dis Sci; 2016 Aug; 61(8):2406-2416. PubMed ID: 27003146
[TBL] [Abstract][Full Text] [Related]
4. Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens.
Ho CC; Chen YC; Hu FC; Yu CJ; Yang PC; Luh KT
Clin Infect Dis; 2009 Jun; 48(11):1526-33. PubMed ID: 19400686
[TBL] [Abstract][Full Text] [Related]
5. The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity.
Robles-Diaz M; Garcia-Cortes M; Medina-Caliz I; Gonzalez-Jimenez A; Gonzalez-Grande R; Navarro JM; Castiella A; Zapata EM; Romero-Gomez M; Blanco S; Soriano G; Hidalgo R; Ortega-Torres M; Clavijo E; Bermudez-Ruiz PM; Lucena MI; Andrade RJ; ;
Liver Int; 2015 Nov; 35(11):2474-82. PubMed ID: 25809419
[TBL] [Abstract][Full Text] [Related]
6. Hepatotoxicity of papaverine.
Kiaer HW; Olsen S; Ronnov-Jessen V
Arch Pathol; 1974 Nov; 98(5):292-6. PubMed ID: 4413667
[No Abstract] [Full Text] [Related]
7. Clinical and histologic features of Azathioprine-induced hepatotoxicity.
Siramolpiwat S; Sakonlaya D
Scand J Gastroenterol; 2017 Aug; 52(8):876-880. PubMed ID: 28388864
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study.
Molleston JP; Fontana RJ; Lopez MJ; Kleiner DE; Gu J; Chalasani N;
J Pediatr Gastroenterol Nutr; 2011 Aug; 53(2):182-9. PubMed ID: 21788760
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network.
Russo MW; Hoofnagle JH; Gu J; Fontana RJ; Barnhart H; Kleiner DE; Chalasani N; Bonkovsky HL
Hepatology; 2014 Aug; 60(2):679-86. PubMed ID: 24700436
[TBL] [Abstract][Full Text] [Related]
10. The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine.
Fontana RJ; Cirulli ET; Gu J; Kleiner D; Ostrov D; Phillips E; Schutte R; Barnhart H; Chalasani N; Watkins PB; Hoofnagle JH
J Hepatol; 2018 Dec; 69(6):1317-1325. PubMed ID: 30138689
[TBL] [Abstract][Full Text] [Related]
11. Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury.
Fontana RJ; Hayashi PH; Barnhart H; Kleiner DE; Reddy KR; Chalasani N; Lee WM; Stolz A; Phillips T; Serrano J; Watkins PB;
Am J Gastroenterol; 2015 Oct; 110(10):1450-9. PubMed ID: 26346867
[TBL] [Abstract][Full Text] [Related]
12. Severe Acute Hepatocellular Injury Attributed to OxyELITE Pro: A Case Series.
Heidemann LA; Navarro VJ; Ahmad J; Hayashi PH; Stolz A; Kleiner DE; Fontana RJ
Dig Dis Sci; 2016 Sep; 61(9):2741-8. PubMed ID: 27142670
[TBL] [Abstract][Full Text] [Related]
13. Fluoroquinolone-induced liver injury: three new cases and a review of the literature.
Licata A; Randazzo C; Morreale I; Butera G; D'Alessandro N; Craxì A
Eur J Clin Pharmacol; 2012 May; 68(5):525-32. PubMed ID: 22246188
[TBL] [Abstract][Full Text] [Related]
14. A case of amoxicillin-induced hepatocellular liver injury with bile-duct damage.
Kim JS; Jang YR; Lee JW; Kim JY; Jung YK; Chung DH; Kwon OS; Kim YS; Choi DJ; Kim JH
Korean J Hepatol; 2011 Sep; 17(3):229-32. PubMed ID: 22102391
[TBL] [Abstract][Full Text] [Related]
15. Quinidine-induced granulomatous hepatitis.
Chajek T; Lehrer B; Geltner D; Levij IS
Ann Intern Med; 1974 Dec; 81(6):774-6. PubMed ID: 4433082
[No Abstract] [Full Text] [Related]
16. Presentations, Causes and Outcomes of Drug-Induced Liver Injury in Egypt.
Alhaddad O; Elsabaawy M; Abdelsameea E; Abdallah A; Shabaan A; Ehsan N; Elrefaey A; Elsabaawy D; Salama M
Sci Rep; 2020 Mar; 10(1):5124. PubMed ID: 32198411
[TBL] [Abstract][Full Text] [Related]
17. Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study.
Paterson JM; Mamdani MM; Manno M; Juurlink DN;
CMAJ; 2012 Oct; 184(14):1565-70. PubMed ID: 22891208
[TBL] [Abstract][Full Text] [Related]
18. Azathioprine and 6-Mercaptopurine-induced Liver Injury: Clinical Features and Outcomes.
Björnsson ES; Gu J; Kleiner DE; Chalasani N; Hayashi PH; Hoofnagle JH;
J Clin Gastroenterol; 2017 Jan; 51(1):63-69. PubMed ID: 27648552
[TBL] [Abstract][Full Text] [Related]
19. Terbinafine-associated hepatic injury.
van 't Wout JW; Herrmann WA; de Vries RA; Stricker BH
J Hepatol; 1994 Jul; 21(1):115-7. PubMed ID: 7963410
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of liver injury in drug-induced systemic hypersensitivity reactions.
Lee T; Lee YS; Yoon SY; Kim S; Bae YJ; Kwon HS; Cho YS; Moon HB; Kim TB
J Am Acad Dermatol; 2013 Sep; 69(3):407-15. PubMed ID: 23632341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
